Braskem downgraded to Sell from Neutral at UBS
Negative outlook consistent with downgrade.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Negative outlook consistent with downgrade.
What happened, with direct paths to the underlying reporting
Braskem downgraded to Sell by UBS; target $1.50; price $2.10.
Target: $1.5
Posted price: $2.1
Analyst firm: UBS
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.